New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
07:33 EDTFMS, MNKMallinckrodt raised Ofirmev price by 140%, says Piper Jaffray
Piper Jaffray says that according to Price Rx, Mallinckrodt (MNK) implemented a 140% price increase for Ofirmev on May 15. Piper views the increase as larger than expected and says it significantly reduces the risk to shares should Fresenius (FMS) launch its Ofirmev generic over the next two years. Piper thinks the risk/reward on shares of Mallinckrodt is compelling and it reiterates an Overweight rating on the stock.
News For MNK;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
07:42 EDTMNKEPAM, WisdomTree added to Franchise Pick list at Jefferies
Subscribe for More Information
December 15, 2014
11:21 EDTFMSCytoSorbents enters strategic partnership with Fresenius Medical
CytoSorbents announced that they have entered into a multi-country strategic partnership with Fresenius Medical Care AG & CO KGaA to commercialize CytoSorbents' CytoSorb therapy. Under the terms of the agreement, Fresenius Medical Care will have the exclusive rights to distribute CytoSorb for critical care applications in France, Poland, Sweden, Denmark, Norway, and Finland. This multi-year agreement is subject to annual minimum guaranteed orders of CytoSorb to maintain exclusivity.
December 11, 2014
07:40 EDTFMSBofA/Merrill to hold a field trip
European Medtech Field Trip is being held in Copenhagen, Denmark on December 11-12.
07:13 EDTFMSDanone to discuss whether to keep or sell medical nutrition unit, Reuters says
According to a source, Danone (DANOY) will hold a board meeting today to discuss whether to keep or sell its medical nutrition business, Reuters reports. Previous reports said Danone's board would decide whether to sell the unit to Hospira (HSP) or Fresenius (FMS), with Fresenius as the possible front-runner to enter exclusive talks. Reference Link
December 9, 2014
14:22 EDTMNKAetna updates clinical policy for H.P. Acthar Gel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use